SJS Investment Consulting »

Zenas Biopharma shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2025-12-31 $255 7 36.43

More positions owned by SJS Investment Consulting

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Ultrashort Fixed (DUSB)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Dimensional Etf Trust Short Duration F (DFSD)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Vanguard Malvern Fds Strm Infproidx (VTIP)
American Centy Etf Tr Avantis Emgmkt (AVEM)
American Centy Etf Tr Us Eqt Etf (AVUS)
Hormel Foods Corporation (HRL)
Dimensional Etf Trust Us Sustainabilty (DFSU)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Dimensional Etf Trust World Ex Us Core (DFAX)
NVIDIA Corporation (NVDA)

View all positions for SJS Investment Consulting

Top funds holding Zenas Biopharma

Sr One Capital Management
FMR
Enavate Sciences GP
NEA Management Company
Federated Investors
Fairmount Funds Management
NVP Associates
BlackRock
Vanguard Group
Novo A/S
Polar Capital Holdings
Wellington Management Company
Vivo Capital
Arrowpoint Asset Management
EcoR1 Capital

View all funds holding Zenas Biopharma